Medicare Enrolled

Dr. Sohrab Yamini, M.D.

Gastroenterology · Los Angeles, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
1700 WESTWOOD BLVD FL 1, Los Angeles, CA 90024
3102346600
In practice since 2006 (19 years)
NPI: 1689601858 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Yamini from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Yamini? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Yamini

Dr. Sohrab Yamini is a gastroenterology specialist in Los Angeles, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Yamini performed 1,659 Medicare services across 1,161 unique beneficiaries.

Between the years covered by Open Payments, Dr. Yamini received a total of $53,375 from 18 pharmaceutical and/or device companies across 65 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Yamini is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 14% volume in CA $53,375 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,659
Medicare services
Top 14% in CA for gastroenterology
1,161
Unique beneficiaries
$63
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~87 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
480 $99 $303
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
282 $12 $47
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
189 $69 $207
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
131 $120 $548
SARS-CoV-2 immunoassay test
A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus.
102 $35 $180
Meperidine hydrochloride injection, per 100 mg
An injection of meperidine hydrochloride, a pain-relieving medication, measured in 100 mg increments.
98 $5 $10
Midazolam injection, per 1 mg
Administration of midazolam hydrochloride, a sedative medication, measured in 1 mg increments.
98 $0 $65
Lactated Ringer's infusion, up to 1000 cc
Intravenous administration of Lactated Ringer's solution, a fluid used to replace fluids and electrolytes, in amounts up to 1000 cubic centimeters.
98 $2 $6
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
86 $70 $12,000
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
43 $152 $15,000
Colon polyp removal with endoscopic snare
This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination.
33 $190 $15,000
Complete ultrasound of retroperitoneum
An ultrasound examination of the structures located behind the abdominal cavity.
19 $92 $290
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
5.9% high complexity
37.7% medium
56.4% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$53,375
Total received (2018-2024)
Avg $7,625/year across 7 years
Top 7% in CA for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
18
Companies
65
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$53,375 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$141
2023
$46
2022
$264
2021
$370
2020
$117
2019
$52,058
2018
$378

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Madrigal Pharmaceuticals
$36
Phathom Pharmaceuticals, Inc.
$33
CapsoVision, Inc.
$28
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$23
Amgen Inc.
$21
Top 3 companies account for 68.8% of 2024 payments
All-time payments by company (2018-2024) ›
Allergan Inc.
$52,069
AbbVie Inc.
$392
Synergy Pharmaceuticals Inc
$176
Takeda Pharmaceuticals U.S.A., Inc.
$110
ABBVIE INC.
$106
Evoke Pharma, Inc.
$95
RedHill Biopharma Inc.
$67
Micro-tech Endoscopy USA, Inc.
$64
EVOKE PHARMA, INC.
$45
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$40
Madrigal Pharmaceuticals
$36
Phathom Pharmaceuticals, Inc.
$33
Gilead Sciences, Inc.
$30
Indivior Inc.
$29
CapsoVision, Inc.
$28
AbbVie, Inc.
$23
Amgen Inc.
$21
ARBOR PHARMACEUTICALS, INC.
$13
Top 3 companies account for 98.6% of all-time payments
Associated products mentioned in payments ›
Amitiza · BOTOX COSMETIC · CREON · CapsoCam Plus · Creon · EUS · Edarbi · GIMOTI · LINZESS · Lockado · Otezla · RESMETIROM · SUBOXONE SUBLINGUAL FILM · TRULANCE · Talicia · Trulance · VIBERZI · VOQUEZNA · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for gastroenterology in CA.

Looking for a gastroenterology specialist in Los Angeles?
Compare gastroenterologists in the Los Angeles area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists within 10 mi
453
Per 100K population
4.6
County median income
$87,760
Nearest hospital
RONALD REAGAN UCLA MEDICAL CENTER
0.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Yamini is a clinical cardiology specialist, with above-average Medicare volume (top 14% in CA), with low-engagement industry engagement in the top 7% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Yamini experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Yamini performed 480 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Yamini receive payments from pharmaceutical companies?
Yes. Dr. Yamini received a total of $53,375 from 18 companies across 65 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Yamini's costs compare to other gastroenterologists in Los Angeles?
Dr. Yamini's average Medicare payment per service is $63. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Yamini) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →